Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Profound Medical Corp

PRN
Current price
11.3 CAD -0.14 CAD (-1.22%)
Last closed 11.24 CAD
ISIN CA74319B5027
Sector Healthcare
Industry Medical Devices
Exchange Toronto Exchange
Capitalization 296 297 971 CAD
Yield for 12 month -11.30 %
1Y
3Y
5Y
10Y
15Y
PRN
21.11.2021 - 28.11.2021

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada. Address: 2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

29.34 CAD

P/E ratio

Dividend Yield

Current Year

+10 125 235 CAD

Last Year

+9 396 680 CAD

Current Quarter

+3 140 665 CAD

Last Quarter

+2 686 373 CAD

Current Year

+6 163 187 CAD

Last Year

+4 248 970 CAD

Current Quarter

+2 022 515 CAD

Last Quarter

+1 784 821 CAD

Key Figures PRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -30 275 148 CAD
Operating Margin TTM -350.78 %
PE Ratio
Return On Assets TTM -35.87 %
PEG Ratio
Return On Equity TTM -66 %
Wall Street Target Price 29.34 CAD
Revenue TTM 7 960 764 CAD
Book Value 1.47 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 39.4 %
Dividend Yield
Gross Profit TTM 3 051 963 CAD
Earnings per share -1.71 CAD
Diluted Eps TTM -1.71 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PRN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 16.10.2019
Dividend Date 16.10.2019

Stock Valuation PRN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 23.3575
Price Sales TTM 37.2198
Enterprise Value EBITDA -7.9326
Price Book MRQ 5.3896

Financials PRN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PRN

For 52 weeks

9.65 CAD 16.16 CAD
50 Day MA 10.85 CAD
Shares Short Prior Month 53 140
200 Day MA 11.6 CAD
Short Ratio 11.47
Shares Short 76 407
Short Percent 0.94 %